Home » Invitrogen Chief Lyle Turner to Step Down Jan. 1; CEO, Chair Posts to Split

Invitrogen Chief Lyle Turner to Step Down Jan. 1; CEO, Chair Posts to Split

Dec 05, 2002

NEW YORK, Dec. 5 - Lyle Turner, the gregarious founder, CEO, and chairman of Invitrogen, will step down at the end of the year, the company said today.

 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Scan

The Same Genes Keep Getting Asked to Prom

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

Keep Them in the Know

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

From Tusk to Cartel

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

This Week in Nature

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2018 GenomeWeb LLC.  All Rights Reserved.